Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Kaiser

Showing results (61-70 of 640) with videos related to

Pageof 64
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|February 4, 2026
Tyrosine kinase inhibitors for wet age-related macular degeneration: The current developmental landscapeRudra Amin, Peter K Kaiser
Current Opinion in Ophthalmology|February 23, 2013
Combination therapy for the treatment of neovascular age-related macular degenerationMiriam Englander, Peter K Kaiser
Therapeutic Advances in Chronic Disease|January 24, 2013
Aflibercept in wet age-related macular degeneration: a perspective reviewMatthew Ohr, Peter K Kaiser
International Ophthalmology Clinics|January 24, 2007
Advances in AMD imagingRishi Singh, Peter K Kaiser
Expert Opinion on Pharmacotherapy|February 4, 2012
Intravitreal aflibercept injection for neovascular (wet) age-related macular degenerationMatthew Ohr, Peter K Kaiser
Seminars in Ophthalmology|May 26, 2011
Emerging therapies for the treatment of neovascular age related macular degenerationAlex Yuan, Peter K Kaiser
The British Journal of Ophthalmology|June 18, 2014
Optical coherence tomography imaging of macular oedemaGeorge Trichonas, Peter K Kaiser
Ophthalmology|August 1, 1997
A study of topical nonsteroidal anti-inflammatory drops and no pressure patching in the treatment of corneal abrasions. Corneal Abrasion Patching Study GroupP K Kaiser, R Pineda
Expert Opinion on Emerging Drugs|February 22, 2014
Emerging treatments for wet age-related macular degenerationAdiel G Smith, Peter K Kaiser
Expert Opinion on Biological Therapy|February 8, 2012
Ranibizumab for age-related macular degenerationDilsher S Dhoot, Peter K Kaiser
Pageof 64

Showing results (61-70 of 640) with videos related to

Sort By:
Pageof 64
The Journal of Pharmacology and Experimental Therapeutics|February 4, 2026
Tyrosine kinase inhibitors for wet age-related macular degeneration: The current developmental landscapeRudra Amin, Peter K Kaiser
Current Opinion in Ophthalmology|February 23, 2013
Combination therapy for the treatment of neovascular age-related macular degenerationMiriam Englander, Peter K Kaiser
Therapeutic Advances in Chronic Disease|January 24, 2013
Aflibercept in wet age-related macular degeneration: a perspective reviewMatthew Ohr, Peter K Kaiser
International Ophthalmology Clinics|January 24, 2007
Advances in AMD imagingRishi Singh, Peter K Kaiser
Expert Opinion on Pharmacotherapy|February 4, 2012
Intravitreal aflibercept injection for neovascular (wet) age-related macular degenerationMatthew Ohr, Peter K Kaiser
Seminars in Ophthalmology|May 26, 2011
Emerging therapies for the treatment of neovascular age related macular degenerationAlex Yuan, Peter K Kaiser
The British Journal of Ophthalmology|June 18, 2014
Optical coherence tomography imaging of macular oedemaGeorge Trichonas, Peter K Kaiser
Ophthalmology|August 1, 1997
A study of topical nonsteroidal anti-inflammatory drops and no pressure patching in the treatment of corneal abrasions. Corneal Abrasion Patching Study GroupP K Kaiser, R Pineda
Expert Opinion on Emerging Drugs|February 22, 2014
Emerging treatments for wet age-related macular degenerationAdiel G Smith, Peter K Kaiser
Expert Opinion on Biological Therapy|February 8, 2012
Ranibizumab for age-related macular degenerationDilsher S Dhoot, Peter K Kaiser
Pageof 64